Interferon-γ Induces a Decrease in the Susceptibility of Human Glioma Cells to Lysis by Lymphokine-activated Killer Cells
- 1 July 1994
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 35 (1) , 113-118
- https://doi.org/10.1227/00006123-199407000-00017
Abstract
WE STUDIED THE effect that treating two types of glioblastoma cell lines, U-87 MG and U-251 MG, with interferon (IFN)-γ had on their susceptibility to lysis by lymphokine-activated killer (LAK) cells. We also examined the participation of cell-adhesion molecules and major histocompatibility complex (MHC) class I and II antigens present on the target cells in lysis by LAK cells. Treatment with IFN-γ (1000 U/ml) for 48 hours resulted in the increased expression of both intercellular-adhesion molecule 1 and MHC class I antigens on tumor cells. In addition, untreated tumor cells expressed neural-cell-adhesion molecules and MHC class II antigens highly, but their expression was not affected by IFN-γ treatment. These changes in expression were accompanied by a decreased susceptibility to lysis by LAK cells. Treatment with antisense-intercellular-adhesion molecule-1 oligonucleotide further inhibited LAK lysis of target cells, following treatment with IFN-γ. In contrast, acid treatment of tumor cells after treatment with IFN-γ increased their susceptibility to lysis by LAK cells. These findings suggest that treatment of glioblastoma cells with IFN-γ decreased their susceptibility to lysis by LAK cells, and that this decrease in susceptibility is attributable principally to the increased expression of MHC class I antigen on target cells.Keywords
This publication has 16 references indexed in Scilit:
- Mechanism of Interferon Gamma-Induced Protection of Human Gliosarcoma Cells from Lymphokine-Activated Killer LysisNeurosurgery, 1992
- Expression of the adhesion molecules ICAM‐1 and ICAM‐2 on tumor cell lines does not correlate with their susceptibility to natural killer cell‐mediated cytolysis: evidence for additional ligands for effector cell β2 integrinsEuropean Journal of Immunology, 1992
- Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.Journal of Clinical Investigation, 1991
- Increased susceptibility of ifn-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cellsInternational Journal of Cancer, 1991
- Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcomaJournal of Neurosurgery, 1988
- Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).The Journal of Experimental Medicine, 1988
- Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)Cell, 1987
- EXPERIMENTAL STRATEGIES AND INTERPRETATIONS IN THE ANALYSIS OF CHANGES IN MHC GENE EXPRESSION DURING TUMOUR PROGRESSIONInternational Journal of Immunogenetics, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982